DongKook Pharmaceutical Co. Ltd (086450) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.79x

DongKook Pharmaceutical Co. Ltd (086450) has a Cash Flow Reinvestment Rate of 0.79x as of March 2026, reinvesting ₩17.94 Billion (capex ₩13.54 Billion plus investments ₩4.40 Billion) from operating cash flow of ₩22.58 Billion. See 086450 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.79x
(Capex + Investments) / Operating CF

Total Reinvested

₩17.94 Billion
Capex + Investments

Operating Cash Flow

₩22.58 Billion
KRW

Capital Expenditures

₩13.54 Billion
KRW

DongKook Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for DongKook Pharmaceutical Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see 086450 operating cash flow.

Annual Cash Flow Reinvestment Rate for DongKook Pharmaceutical Co. Ltd (2013–2025)

Year-by-year capital reinvestment analysis for DongKook Pharmaceutical Co. Ltd. See 086450 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 1.17x ₩80.24 Billion ₩68.76 Billion ₩46.00 Billion ▼ -7.2%
2024 1.26x ₩95.67 Billion ₩76.09 Billion ₩30.80 Billion ▼ -42.7%
2023 2.20x ₩91.74 Billion ₩41.79 Billion ₩39.35 Billion ▲ +41.1%
2022 1.56x ₩63.64 Billion ₩40.91 Billion ₩51.23 Billion ▲ +2.7%
2021 1.52x ₩67.66 Billion ₩44.65 Billion ₩51.01 Billion ▲ +0.7%
2020 1.51x ₩88.96 Billion ₩59.11 Billion ₩39.61 Billion ▲ +76.4%
2019 0.85x ₩59.29 Billion ₩69.48 Billion ₩25.13 Billion ▼ -69.8%
2018 2.83x ₩93.82 Billion ₩33.21 Billion ₩75.46 Billion ▲ +304.7%
2017 0.70x ₩20.01 Billion ₩28.66 Billion ₩11.67 Billion ▲ +93.4%
2016 0.36x ₩14.22 Billion ₩39.41 Billion ₩9.62 Billion ▼ -47.1%
2015 0.68x ₩18.51 Billion ₩27.14 Billion ₩9.60 Billion ▼ -9.0%
2014 0.75x ₩17.05 Billion ₩22.74 Billion ₩13.59 Billion ▲ +272.9%
2013 0.20x ₩3.99 Billion ₩19.86 Billion ₩3.99 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow